RGLHX | RWIBX | RGLHX / RWIBX | |
Total Expense Ratio | 1.24 | 1.51 | 82% |
Annual Report Gross Expense Ratio | 1.24 | 1.51 | 82% |
Fund Existence | 6 years | 23 years | - |
Gain YTD | 15.220 | 14.943 | 102% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18B | 137B | 13% |
Annual Yield % from dividends | 0.44 | 0.82 | 54% |
Returns for 1 year | 15.33 | 10.52 | 146% |
Returns for 3 years | 43.06 | 38.46 | 112% |
Returns for 5 years | 57.85 | 43.49 | 133% |
Returns for 10 years | N/A | 59.55 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IYH | 57.43 | 0.95 | +1.68% |
iShares US Healthcare ETF | |||
FID | 19.92 | 0.02 | +0.10% |
First Trust S&P Int Div Aristocrats ETF | |||
PBSE | 28.41 | N/A | N/A |
PGIM S&P 500 Buffer 20 ETF - Sep | |||
XEMD | 43.58 | -0.01 | -0.02% |
BondBloxx JP Morgan USD EM 1-10 Yr BdETF | |||
CAAA | 20.48 | -0.02 | -0.07% |
First Trust Commercial Mortg Opports ETF |